Current issues in Wilms tumor management

Current Problems in Cancer

Volumn 29, Issue 5, 2005, Pages 223-260

  Grundy, Paul ^a,b,j,k,l,m   Perlman, Elizabeth ^c,n   Rosen, Nancy S ^d,o,p,q   Warwick, Anne B ^e,r   Bender, Julia Glade ^f,o   Ehrlich, Peter ^g,o   Hoffer, Fredric A ^h,o   Lee, Nadine Deannie ^i,o  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c NORTHWESTERN UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

^h ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

ⁱ INDIANA UNIVERSITY   (United States)

^j Renal Tumors Committee   (United States)

^k Royal College of Physicians of Canada   (Canada)

^l AMERICAN BOARD OF PEDIATRICS   (United States)

^m AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

ⁿ CHILDREN'S MEMORIAL HOSPITAL   (United States)

^o CHILDREN S ONCOLOGY GROUP   (United States)

^p WEILL CORNELL MEDICAL COLLEGE   (United States)

^q Cornell University Medical College ^*

^r Children s Hospital of Wisconsin   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BEVACIZUMAB; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEPSIPEPTIDE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; HISTONE DEACETYLASE INHIBITOR; IFOSFAMIDE; IRINOTECAN; LENALIDOMIDE; OBLIMERSEN; OXALIPLATIN; PEMETREXED; TEMOZOLOMIDE; TIPIFARNIB; TOPOTECAN; VASCULOTROPIN; VINCRISTINE;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BIOPSY; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; DEEP VEIN THROMBOSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG HALF LIFE; EPISTAXIS; HISTOLOGY; HUMAN; HYPERTENSION; IMAGING; IMMUNOHISTOCHEMISTRY; INJECTION SITE REACTION; LUNG METASTASIS; MUTATION; NEPHROBLASTOMA; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEINURIA; RADIATION DOSE; RADIOGRAPHY; REVIEW; RISK ASSESSMENT; SURVIVAL TIME; TOXICITY; INFANT; KIDNEY TUMOR; LUNG TUMOR; METASTASIS; PATHOLOGY; PRESCHOOL CHILD;

CHILD, PRESCHOOL; HUMANS; INFANT; KIDNEY NEOPLASMS; LUNG NEOPLASMS; WILMS TUMOR;

EID: 84861269785     PISSN: 01470272     EISSN: 15356345     Source Type: Journal    
DOI: 10.1016/j.currproblcancer.2005.08.002     Document Type: Article

References (102)

1. P.E. Grundy, D.M. Green, M.J. Coppes, N.E. Breslow, M.L. Ritchey, E.J. Perlman Renal tumors P.A. Pizzo D.G. Poplack Principles and Practice of Pediatric Oncology 2002 Lippincott Williams & Wilkins Philadelphia, PA 865 893
2. R.C. Shamberger, K.A. Guthrie, M.L. Ritchey, G.M. Haase, J. Takashima, J.B. Beckwith Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study-4 Ann Surg 229 2 1999 292 297
3. P. Ehrlich, M. Ritchey, T. Hamilton, G. Haase, S. Ou, N. Breslow Quality assessment for Wilms Tumor a report from the National Wilms' Tumor Study-5 J Pediatr Surg 40 2005 208 213
4. M.L. Ritchey, P.P. Kelalis, N. Breslow, R. Etzioni, I. Evans, G.M. Haase Surgical complications after nephrectomy for Wilms tumor Surg Gynecol Obstet 175 1992 507 514
5. M.L. Ritchey, D.M. Green, P.R.M. Thomas, G.R. Smith, G. Haase, S. Shochat Renal failure in Wilms' tumor patients a report from the National Wilms' Tumor Study Group Med Pediatr Oncol 26 1996 75 80
6. N.E. Breslow, J.R. Takashima, M.L. Ritchey, L.C. Strong, D.M. Green Renal failure in the Denys-Drash and Wilms; tumor-aniridia syndromes Cancer Res 60 15 2000 4030 4032
7. J.F. Bonadio, B. Storer, P. Norkool, V.T. Farewell, J.B. Beckwith, G.J. D'Angio Anaplastic Wilms tumor clinical and pathologic studies J Clin Oncol 3 1985 513 520
8. P. Faria, J.B. Beckwith, K. Mishra, C. Zuppa, D.A. Weeks, N. Breslow Focal versus diffuse anaplasia in Wilms tumor - New definitions with prognostic significance Am J Surg Pathol 20 8 1996 909 920
9. J.B. Beckwith National Wilms Tumor Study an update for pathologists Pediatr Dev Pathol 1 1998 79 84
10. D.M. Green, N.E. Breslow, I. Evans, J. Moksness, J.Z. Finklestein, A.E. Evans The effect of chemotherapy dose intensity on the hematological toxicity of the treatment for Wilms' tumor. A report of the National Wilms Tumor Study Am J Pediatr Hematol Oncol 16 1994 207 212
11. D.M. Green, N.E. Breslow, I. Evans, J. Moksness, J.Z. Finklestein, A.E. Evans Relationship between dose schedule and charges for treatment on National Wilms' tumor Study-4. A report from the National Wilms' Tumor Study Group J Natl Cancer Inst Monogr 19 1995 21 25
12. D.M. Green, N.E. Breslow, J.B. Beckwith, J.Z. Finklestein, P.E. Grundy, P.R.M. Thomas Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor a report from the National Wilms' tumor study group J Clin Oncol 16 1 1998 237 245
13. D.M. Green, N.E. Breslow, J.B. Beckwith, J.Z. Finklestein, P. Grundy, P.R. Thomas Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor a report from the National Wilms' Tumor Study Group J Clin Oncol 16 12 1998 3744 3751
14. G.J. D'Angio, A.E. Evans, N. Breslow, B. Beckwith, H. Bishop, P. Feigl The treatment of Wilms' tumor Cancer 38 1976 633 646
15. G.J. D'Angio, A. Evans, N. Breslow, B. Beckwith, H. Bishop, V. Farewell The treatment of Wilms' Tumor results of the Second National Wilms' Tumor Study Am Cancer Soc 4 1981 2302 2310
16. P.R.M. Thomas, M. Tefft, P.J. Compaan, P. Norkool, N.E. Breslow, G.J. D'Angio Results of two radiotherapy randomizations in the Third National Wilms' Tumor Study (NWTS-3) Cancer 68 1991 1703 1707
17. J.A. Meisel, K.A. Guthrie, N.E. Breslow, S.S. Donaldson, D.M. Green Significance and management of computed tomography detected pulmonary nodules a report from the National Wilms Tumor Study Group Int J Radiat Oncol Biol Phys 44 3 1999 579 585
18. D.M. Green, J.B. Beckwith, N.E. Breslow, P. Faria, J. Moksness, J.Z. Finklestein Treatment of children with stages II to IV anaplastic Wilms' tumor a report from the National Wilms' Tumor Study Group J Clin Oncol 12 10 1994 2126 2131
19. Society of International Pediatric Oncology (SIOP) Wilms Tumor Protocol 2001.
20. D. Green, P. Grundy, R. Shamberger, M. Ritchey National Wilms Tumor Study Group V Protocol 1995 https://members.childrensoncologygroup.org/Disc/surgery/ surgicalHbooks.asp.
21. K. McHugh, K. Pritchard-Jones Problems in the imaging of three common paediatric solid tumours Eur J Radiol 37 2001 72 78
22. G. D'Angio, H. Rosenberg, K. Sharples, P. Kelalis, N.E. Breslow, D.M. Green Position paper: imaging methods for primary renal tumors of childhood: cost versus benefits Med Ped Oncol 21 1993 205 212
23. C.M. Owens, P.A. Veys, J. Pritchard, G. Levitt, J. Imeson, C. Dicks-Mireaux Role of chest computed tomography at diagnosis in the management of Wilms' tumor a study by the United Kingdom Children's Cancer Study Group J Clin Oncol 20 12 2002 2768 2773
24. M. Ditchfield, J. DeCampo, K. Waters, T. Nolan Wilms' tumor A rational use of preoperative imaging Pediatr Oncol 24 1995 93 96
25. S. Wootton-Gorges, E.A. Albano, J.M. Riggs, H. Ihrke, C.M. Rumack, J.D. Strain Chest radiography versus chest CT in the evaluation for pulmonary metastases in pateints with Wilms tumor a retrospective review Pediatr Radiol 30 1999 533 539
26. M. Cohen, W.L. Smith, R. Weetman, A. Provisor Pulmonary pseudometastases in children with malignant tumors Radiology 141 1981 371 374
27. Ehrlich PF, Hamilton TE, Grundy P, et al. The value of surgery in directing therapy of Wilms tumor patients with pulmonary diseasse. A report from the National Wilms Tumor Study Group. J Pediatr Surg; in press.
28. J.A. Wilimas, S.C. Kaste, W.M. Kauffman, H. Winer-Muran, R. Morris, X. Luo Use of chest computed tomography in the staging of pediatric Wilms' tumor interobserver variability and prognostic significance J Clin Oncol 15 7 1997 2631 2635
29. S.P. Attard-Monalto, J.E. Kingston, O.B. Eden, P.N. Plowman Late follow-up of lung function after whole lung irradiation for Wilms' tumour The British J Radiol 66 1992 1114 1118
30. D.M. Green Effects of treatment for childhood cancer on vital organ systems Cancer 15 2005 3299 3305
31. S. Margrini, M. Papi, R. Bagnoli, J.S. Dome, S. Bianchi, P. Bitoun Late sequlae involving the breas after radiotherapy for lung metastases of Wilms tumor. Experience of the Florence radiotherapy and analysis of the literature Radio Med (Torino) 89 1995 865 869
32. A.C. Paulino, B.C. Wen, C.K. Brown, R. Tannous, N.A. Mayr, W.K. Zhen Late effects in children treated with radiation therapy for Wilms tumor Int J Rad Oncol 46 2000 1239 1246
33. D.M. Green, N.E. Breslow, J. Moksness, G.J. D'Angio Congestive heart failure following initial therapy for Wilms tumor AACR 1998 161A
34. J.L. Grosfeld Risk-based management current concepts of treating malignant solid tumors of childhood J Am Coll Surg 189 4 1999 407 435
35. D.M. Green, B. Nan, Y. Grigoriev, J. Takashima, P. Norkool, G.J. D'Angio Congestive heart failure (CHF) after treatment for Wilms tumor. A report from the National Wilms Tumor Study Group 2002 Notes.
36. D.M. Green, Y.A. Grigoriev, B. Nan, J.R. Takashima, P.A. Norkool, G.J. D'Angio Congestive heart failure after treatment for Wilms' tumor a report from the National Wilms' Tumor Study Group J Clin Oncol 19 7 2001 1926 1934
37. P. Shearer, G. Kapoor, J.B. Beckwith Secondary acute myelogenous leukemia in patients previously treated for childhood renal tumors a reprot from the National Wilms Tumor Study Group J Pediatr Hematol Oncol 23 2001 109 111
38. D.M. Green Use of chest computed tomography for staging and treatment of Wilms' tumor in children J Clin Oncol 20 12 2002 2763 2764
39. D.M. Green, D.J. Fernbach, P. Norkool, G. Kollia, G.J. D'Angio The treatment of Wilms tumor patients with pulmonary metastases detected only with computed tomography a report from the National Wilms Tumor Study J Clin Oncol 9 1991 1776 1781
40. A. Dirks, S. Li, N. Breslow, P. Grundy Outcome of patients with lung metastases on NWTS 4 and 5 Med Pediatr Oncol 41 4 2003 251 252
41. J.A. Wilimas, E.C. Douglass, H.L. Magil, S. Fitch, H.O. Hustu Significance of pulmonary computed tomography at diagnosis in Wilms' tumor J Clin Oncol 6 1988 1144 1146
42. V. Gylys-Morin, F.A. Hoffer, H. Kozakewich, R.C. Shamberger Wilms tumor and nephroblastomatosis imaging characteristics at gadolinium-enhanced MR imaging Radiology 188 1993 517 521
43. C.S. Cooper, W.I. Jaffe, D.S. Huff, D.A. Canning, S.A. Zderic, A.T. Meadows The role of renal salvage procedures for bilateral Wilms tumor a 15-year review J Urol 163 2000 265 268
44. Perlman E, Faria P, Hoffer FA, Sredni ST, Ritchey M, Shamberger RC, et al. Hyperplastic perilobar nephroblastosis: long-term survival of 52 patients. Pediatr Blood Cancer; in press.
45. K.M. Garrett, C. Fuller, V. Santana, S. Shochat, F.S. Hoffer Percutaneous biopsy of pediatric solid tumors Cancer 104 3 2005 644 652
46. B.T. Montgomery, P.P. Kelalis, M.L. Blute, E.J. Bergstrahl, J.B. Beckwith, P. Norkool Extended follow up of bilateral Wilms' tumor study results of the National Wilms' Tumor Study J Urol 146 1991 514 518
47. M.L. Ritchey, P.P. Kelalis, G.M. Haase, S.J. Schochat, D.M. Green, G. D'Angio Preoperative therapy for intracaval and atrial extension of Wilms tumor Cancer 71 1993 4104 4110
48. M.L. Ritchey, D.M. Green, P. Thomas, G. Haase, S. Shochat Accuracy of current imaging modalities in the diagnosis of synchronous bilateral Wilms' tumor a report from the National Wilms' Tumor Study Group J Urol 151 1994 329A
49. N. Daw, W. Kauffman, S. Bodner, C. Pratt, F. Hoffer Patterns of abdominal relapse and role of sonography in Wilms tumor Pediatr Hematol Oncol 19 2002 107 115
50. T.L. Slovis Children, computed tomography radiation dose, and the As Low As Resonably Achievable (ALARA) concept Pediatrics 112 2003 971 972
51. W. Rohrschneider, A. Weirich, K. Rieden, K. Darge, J. Troger, N. Graf US, CT and MR imaging characteristics of nephroblastomatosis Pediatr Radiol 28 1998 435 443
52. M. Ritchey, B. Broecker Surgical complications following nephrectomy for Wilms tumor Med Pediatr Oncol 41 4 2003 251
53. J.S. Dome, T. Liu, M. Krasin, L. Lott, P. Shearer, N.C. Daw Improved survival for patients with recurrent Wilms tumor the experience at St. Jude Children's Research Hospital J Pediatr Hematol Oncol 24 3 2002 192 198
54. P. Grundy, N.E. Breslow, D.M. Green, K. Sharples, A. Evans, G.J. D'Angio Prognostic factors of children with recurrent Wilms tumor Results from the second and third National Wilms Tumor Study J Clin Oncol 7 1989 638 647
55. R. Tannous, G. Giller, E. Holmes, T. Kim, M. LaQuaglia, M.M. Malogolowkin Intensive therapy for high risk (HR) relapsed Wilms' tumor (WT). A CCG-4921/POG-9445 study report Proc ASCO 19 2000 588a
56. A.M. Abu-Ghosh, M.D. Krailo, S.C. Goldman, R.S. Slack, V. Davenport, E. Morris Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor a Children's Cancer Group report Ann Oncol 13 2002 460 469
57. A. Weirich, R. Ludwig, N. Graf, U. Abel, I. Leuschner, G. Vujanic Survival in nephroblastoma treated according to the trial and study SIOP-9/GPOH with respect to relapse and morbidity Ann Oncol 15 2004 808 820
58. N.M. Marina, J.H. Rodman, D.J. Murry, S.J. Shema, L.C. Bowman, D.P. Jones Phase I Study of escalating targeted doeses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors J Natl Cancer Inst 86 7 1994 544 548
59. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertenstein, G. Breier Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Nature 380 6573 1996 435 439
60. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K.S. O'Shea Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 6573 1996 439 442
61. N. Ferrara, H. Gerber, J. LeCouter The biology of VEGF and its receptors Nat Med 9 6 2003 669 676
62. J. Glade-Bender, J.J. Kandel, D. Yamashiro VEGF blocking therapy in the treatment of cancer Expert Opin Biol 3 2 2003 263 276
63. A.D. Blann, J.L. Li, C. Li, S. Kumar Increased serum VEGF in 13 children with Wilms' tumour falls after surgery but rising levels predict poor prognosis Cancer Lett 173 2001 183 186
64. M.A. Ghanem, G.J. van Steenbrugge, M.K. Sudaryo, R.B. Mathoera, J.M. Nijman, H. van der Kwast Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma J Clin Pathol 56 2004 107 113
65. W. Li, P. Kessler, H. Yeger, J. Alami, A.E. Reeve, R. Heathcott A gene expression signature for relapse of primary Wilms tumors Cancer Res 65 7 2005 2592 2601
66. A.M. Davidoff, A.C. Nathwani, W.W. Spurbeck, C.Y. Ng, J. Zhou, E.F. Vanin rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice Cancer Res 62 11 2002 3077 3083
67. D.H. Rowe, J. Huang, M.L. Kayton, R. Thompson, A. Troxel, K.M. O'Toole Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor J Ped Surg 35 1 2000 30 33
68. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips Inhibition of vascular endotherlial growth factor-induced angiogenesis suppresses tumor growth in vivo Nature 362 6423 1993 841 844
69. J. Huang, J. Moore, S. Soffer, E. Kim, D. Rowe, C.A. Manley Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors J Pediat Surg 36 2 2001 357 361
70. J.S. Frischer, J. Huang, A. Serur, A. Kadenhe-Chiweshe, K.W. McCrudden Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature Int J Oncol 25 3 2004 549 553
71. J. Huang, J.S. Frischer, A. Serur, A. Kadenhe, A. Yokoi, K.W. McCrudden Regression of established tumors and metastases by potent vascular endothelial growth factor blockade Proc Natl Acad Sci USA 100 13 2003 7785 7790
72. J. Huang, S.Z. Soffer, S. Kim, K.W. McCrudden, J. Huang, T. New Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis Mol Can Res 2 1 2004 36 42
73. S.Z. Soffer Combination antiangiogenic therapy increased efficacy in a murine model of Wilms tumor J Pediatr Surg 36 8 2001 1177 1181
74. N. Ferrara, K.J. Hillan, H.P. Gerber, W. Novotny Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer Nat Rev Drug Discov 3 5 2004 391 400
75. M.S. Gordon, K. Margolin, M. Talpaz, G.W. Sledge Jr, E. Holmgren, R. Benjamin Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer J Clin Oncol 19 3 2001 843 850
76. J.C. Yang, L. Haworth, R.M. Sherry, P. Hwu, D.J. Schwartzentruber, S.L. Topalian A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer N Engl J Med 349 5 2003 843 850
77. D.R. Spigel bevacizumab and erlotinib in the treatment of patients with metastatic renal carcinoma (RCC) update of Phase II multicenter trial Proc Am Soc Clin Oncol 24 2005 4540
78. R.J. Motzer, R. Amato, M. Todd, W.J. Hwu, R. Cohen, J. Baselga Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma Invest New Drugs 21 1 2003 99 101
79. B. Drucker, J. Bacik, M. Ginsberg, S. Marion, P. Russo, M. Mazumdar Phase II trial of ZD1839 (IRESSA) in patients with advanced renal cell carcinoma Invest New Drugs 21 3 2003 341 345
80. A. Yokoi, K.W. McCrudden, J. Huang, E.S. Kim, S.Z. Soffer, J.S. Frischer Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms tumor J Pediat Surg 38 11 2003 1569 1573
81. P. Borgstrom, D.P. Gold, K.J. Hillan, N. Ferrara Importance of VEGF for breast cancer angiogenesis in vivo implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin Anticancer Res 19 5B 1999 4203 4214
82. G. Klement, S. Baruchel, J. Rak, S. Man, K. Clark, D.J. Hicklin Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity J Clin Invest 105 8 2000 R15 R24
83. G. Klement Differences in therapeutic indexes of combination metronomic chemotherapy and anti-VEGFR-2 antibody in multidrug-resistant human breast cancer xenografts Clin Cancer Res 8 1 2002 221 232
84. H. Hurwitz, L. Fehrenbacher, W. Novotny, T. Cartwright, J. Hainsworth, W. Heim Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 23 2004 2335 2342
85. F. Kabbinavar, H.I. Hurwitz, L. Fehrenbacher, N.J. Meropol, W.F. Novotny, G. Lieberman Phase II, randomized trail comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 21 1 2003 60 65
86. V. Santana, W. Zamboni, A. Gaijar, A. Pappo, P. Houghton, W. Meyer Pharmacokinetically-guided use of topotecan (TPT), given (daily × 5) × 2, in children with relapsed solid tumors Proc ASCO 16 1997 511a
87. M. Cosetti, L.H. Wexler, E. Calleja, T. Trippett, M. LaQuaglia, A.G. Huevos Irinotecan for pediatric solid tumors the Memorial Sloan-Kettering experience J Pediatr Hematol Oncol 24 2002 101 105
88. A.S. Pappo Irinotecan (CPT-11) is active against pediatric rhabdomyosarcoma (RMS) a Phase II window trail from the Soft Tussue Sarcoma Committee (STS) of the Children's Oncology Group Proc Am Soc Clin Oncol 2002 21
89. C. Pratt Phase I study of oxaliplatin in pediatric patiens with malignant solid tumors Proc Am Soc Clin Onc 20 2001
90. I. Kausch, H. Jiang, B. Thode, C. Doehn, S. Kruger, D. Jocham Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma Eur Urol 47 2005 703 709
91. R. Thodtmann, T. Sauter, S. Weinknecht, L. Weissbach, J. Blatter, U. Ohnmacht A phase II trial of pemetrexel in patients with metastatic renal cancer Invest New Drugs 21 2003 353 358
92. N. Bardeesy, D. Falkoff, M.-J. Petruzzi, N. Nowak, B. Zabel, M. Adam Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations Nat Genet 7 1994 91 97
93. M.A. Ghanem, G.J. van Steenbrugge, R.J. Nijman, T.H. van der Kwast Prognostic markers in nephroblastma (Wilms' tumor) Urology 65 2005 1047 1054
94. A. Eggert, M.A. Grotzer, N. Ikegaki, H. Zhao, A. Cnaan, G.M. Brodeur Expression of the neurotrophin receptor TrkB is associated with unfavorable outcome in Wilms tumor J Clin Oncol 19 3 2001 689 696
95. S.R. Knezevich, M.J. Garnett, T.J. Pysher, J.B. Beckwith, P.E. Grundy, P.H.B. Sorensen ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma Cancer Res 58 1998 5046 5048
96. P. Argani, M. Ladanyi Recent advances in pediatric renal neoplasia Adv Anat Path 10 2003 243 260
97. S.D. Safford, A.J. Freemerman, S. Langdon, R. Bentley, D. Goyeau, P.E. Grundy Decreased e-cadherin expression correlates with higher stage of Wilms' tumors J Pediatr Surg 40 2005 341 348
98. J.S. Dome, S. Chung, T. Bergemann, C.B. Umbricht, M. Saji, L.A. Carey High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor Cancer Res 59 1999 4301 4307
99. R.D. Williams, S.N. Hing, B.T. Greer, C.C. Whiteford, J.S. Wei, R. Natrajan Prognostic classification of relapsing favorable histology Wilms tumor using cDNA microarray expression profiling and support vector machines Genes Chromosomes Cancer 41 1 2004 65 79
100. W. Li, P. Kessler, H. Yeger, J. Alami, A.E. Reeve, R. Heathcott A gene expression signature for relapse of primary Wilms Tumors Cancer Res 65 2005 2592 2601
101. W. Li, P. Kessler, H. Yerger, J. Alami, A. Reeve, R. Heathcott A gene epression signature for relapse of primary Wilms Tumors Cancer Res 65 7 2005 2592 2601
102. M. Takahashi, X.J. Yang, T.T. Lavery, K.A. Furge, B.O. Williams, M. Tretiakova Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features Cancer Res 62 22 2002 6598 6605